An Open Label Comparing the Short Term Efficacy of Lacrisert
NCT03079271
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Dry Eye
Interventions
DRUG:
Lacrisert, 5 Mg Ophthalmic Insert
Sponsor
Virginia Eye Consultants